Novartis (skin cancer drug)

Business Data, Corporate Office and Headquarter Address

About

Novartis (skin cancer drug) is Buildings and Property in Switzerland that focus on radiation therapy business. They cover business area such as Odomzo, Novartis, adult patient, locally advanced basal cell carcinoma, surgery, radiation therapy, candidate.

Business Type

Buildings and Property

Country

Switzerland

Founded

-

Company Focus

Radiation Therapy

Website

-

Corporate Office and Headquarter Office address:

Basel
Switzerland

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

OdomzoNovartisadult patientlocally advanced basal cell carcinomasurgeryradiation therapycandidate

* We use standard office opening hours in near Novartis (skin cancer drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Novartis (skin cancer drug) Frequently Asked Questions

What or who is Novartis (skin cancer drug)?

Novartis (skin Cancer Drug) is Buildings and Property business from Switzerland that founded in - ( years old in ), Novartis (skin cancer drug) business is focusing on Radiation Therapy.

Where is Novartis (skin cancer drug) headquarter and corporate office address?

Novartis (skin cancer drug) headquarter office and corporate office address is located in Basel Switzerland.

Where is Novartis (skin cancer drug) country origins?

Novartis (skin cancer drug) was founded in Switzerland.

What is Radiation Therapy business focus on?

In , Novartis (skin cancer drug) is currently focus on radiation therapy sector.

Radiation Therapy Business Interest from Google Trend

Above is snippet of Google Trends for "radiation therapy" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Novartis (skin cancer drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.